Search results
Results from the Go Local Guru Content Network
As of 2023, Dana-Farber is ranked the #4 cancer hospital in the world. Two Nobel laureates in Physiology or Medicine are among its past and present faculty. Dana-Farber's research discoveries include the development of the highly successful Gleevec to treat chronic myeloid leukemia.
Sidney Farber (September 30, 1903 – March 30, 1973) was an American pediatric pathologist. He is regarded as the father of modern chemotherapy for his work using folic acid antagonists to combat leukemia , which led to the development of other chemotherapeutic agents against other malignancies.
Catherine J. Wu is an American physician-scientist who studies oncology. She is a Professor of Medicine and Chief of Division of Stem Cell Transplantation and Cellular Therapies at the Dana–Farber Cancer Institute.
The picket comes after a federal mediator was called in to assist with negotiations between the Massachusetts Nurses Association and the Dana-Farber Cancer Institute - Merrimack Valley.
On Thursday, amid some sweltering heat, L + M broke ground on a new cancer center with Dana Farber at its side, which will be the only cancer center in Connecticut that can call the renowned ...
Irene Ghobrial is an American-Egyptian physician who is a professor at the Dana–Farber Cancer Institute and Harvard Medical School, where her research investigates the progression of multiple myeloma.
Her parents contacted Dana-Farber that same day where she underwent a biopsy that indicated she had Hodgkin’s lymphoma and immediately began treatment.
William G. Kaelin Jr. (born November 23, 1957) is an American Nobel laureate physician-scientist. He is a professor of medicine at Harvard University and the Dana–Farber Cancer Institute. His laboratory studies tumor suppressor proteins.
FOXBOROUGH, MA — The Dana-Farber Cancer Institute will occupy the new medical office being constructed at Patriot Place. The medical center and shopping center both announced Thursday that...
Currently, he is the principal investigator of the Dana-Farber/Harvard Cancer Center NCI SPORE (National Cancer Institute Specialized Program of Research Excellence) in breast cancer. His research group focuses on improving care through the development of new treatment approaches.